Login
Aug 06, 2013
Luitpold Pharmaceuticals, Inc. Provides Adequan® (polysulfated glycosaminoglycan) Supply Update
Luitpold Animal Health, a division of Luitpold Pharmaceuticals, Inc., manufacturers of Adequan® IM, Adequan® IA, and Adequan® Canine provide the following supply interruption update:
In 2012, Luitpold renovated and upgraded its Shirley, New York manufacturing facility as part of its commitment to improving the quality of its operations. These renovations affected Luitpold’s ability to manufacture and release Adequan®, resulting in the current shortages that exist in the marketplace.
Luitpold has been working closely with the Food and Drug Administration to assure that Adequan® is made available as soon as possible. As a result of these efforts, we have been able to revise our target date for product availability from our original estimate of the first quarter 2014. We now anticipate release of Adequan® products to the market beginning in late August, 2013.
Luitpold remains committed to resuming its manufacture and release of Adequan® products. We understand how critically important the Adequan® brands are to the health and well-being of the animals receiving treatment.
The company has established a dedicated webpage on www.adequan.com where concerned parties can register to receive future communications and updates on this matter. You may also contact our Customer Service Department at 1-800-458-0163.
Adequan® IM and IA are the only polysulfated glycosaminoglycan (PSGAG) approved by the FDA for the treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness in horses. Adequan® Canine is the only polysulfated glycosaminoglycan (PSGAG) approved by the FDA for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints.
Contact
Allyn Mann, Director
Luitpold Animal Health
Cell Phone: 816-590-5032
Email: [email protected]
Apr 27, 2025
Competitions
23 to Move Forward to Show Jumping in Defender Kentucky CCI5*-L
It was a somewhat uneventful morning in the final horse inspection for both the Cosequin Lexington CCI4*-S and Defender Kentucky CCI5*-L, which is always a great testament to the exemplary horse care that these top athletes receive and the horsemanship exhibited by their riders.
Apr 27, 2025
Competitions
The 2025 K3DE Daily: Show Jumping Day
And just like that, it's the final day of the Defender Kentucky Three-Day Event and it's a full one in terms of the schedule. Before moving on to the final phase, competitors in both the CCI4*-S and CCI5*-L divisions will have to undergo the final horse inspection at High Hope Lane which will kick off with four-star competitors at 8 a.m. EST and be followed immediately by the five-star contingency.
Apr 26, 2025
Eventing News
Coleman and Off The Record Make Easy Work of Cosequin Lexington CCI4*-S Cross-Country
When Will Coleman, the overnight leader in the Cosequin Lexington CCI4*-S division at the Defender Kentucky Three-Day Event, walked Derek di Grazia’s cross-country track, he knew time was going to play a major factor in how the results would shake out upon the completion of the second phase.
Apr 26, 2025
Competitions
Martin Comes Close, But Jung Strengthens His Lead at Defender Kentucky CCI5*-L
“I really love riding the horses,” said Michael Jung. “I do it every day— riding the horses, training the horses, going to many, many competitions. I am really into the sport and with horses. I know it can go wrong all the time. So I try to go out, do my best, take care of the horse; if it went wrong, OK. It can happen, now you just be prepared for the next day.”
